Retail News

FDA Considers OTC Fat Blocker

The Associated Press/iWon.com 01/20/2006

The Food and Drug Administration is deciding if it should accept GlaxoSmithKline Consumer Healthcare’s proposal to market its Alli (pronounced “ally”) fat blocker medication for sale over-the-counter.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!